TFCP2L1 Drives Stemness and Enhances Their Resistance to Sorafenib Treatment by Modulating the NANOG/STAT3 Pathway in Hepatocellular CarcinomaDongbo Qiu,Tiantian Wang,Yi Xiong,Kun Li,Xiusheng Qiu,Yuan Feng,Qinghai Lian,Yunfei Qin,Kunpeng Liu,Qi Zhang,Changchang JiaONCOGENESIS(2024)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要